{"eventGroups":[{"description":"Patients receive celecoxib PO BID for 6 months in the absence of unacceptable toxicity or progression to malignancy.","id":"EG000","otherNumAffected":6,"otherNumAtRisk":11,"seriousNumAffected":0,"seriousNumAtRisk":11,"title":"Arm I (Celecoxib)"},{"description":"Patients receive placebo PO BID for 6 months in the absence of unacceptable toxicity or progression to malignancy.","id":"EG001","otherNumAffected":8,"otherNumAtRisk":12,"seriousNumAffected":0,"seriousNumAtRisk":12,"title":"Arm II (Placebo)"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":4,"numAtRisk":12,"numEvents":4}],"term":"headache"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":12,"numEvents":2}],"term":"Fatigue"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":12,"numEvents":1}],"term":"Pruritus/Itching"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":12,"numEvents":1}],"term":"Diarrhea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":12,"numEvents":0}],"term":"Constipation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":12,"numEvents":1}],"term":"Dizziness"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":12,"numEvents":0}],"term":"Neuorpathy"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":12,"numEvents":1}],"term":"Back Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":2,"numAtRisk":12,"numEvents":5}],"term":"Exremity Limb Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":11,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":12,"numEvents":1}],"term":"Neck Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":11,"numEvents":0},{"groupId":"EG001","numAffected":2,"numAtRisk":12,"numEvents":2}],"term":"Pain NOS"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":11,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":12,"numEvents":1}],"term":"Upper Respiratory"}]}